Sue Brown
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Sue Brown sits in the upper quartile of US sponsors by registered trial count (#2,085 of 15,742 sponsors by registered trial count).
Sue Brown: 6 sponsored US clinical trials, 3 recruiting.
Sue Brown sponsors 6 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 1 completed. The most-studied condition in this pipeline is Type 1 Diabetes, with 2 trials.
Upper-quartile sponsor footprint
Sue Brown sits in the upper quartile of the sponsor corpus (#2,085 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
6 total, page 1 of 1
Insulin Delivery With Self-Adjusting Closed-Loop and Behavioral Glycemic Control Enhanced by Prediction
NCT07507708
AIDANET At Home Study
NCT07039617
Safety and Feasibility of a Machine-Learning Bolus Priming Added to Existing Control Algorithm
NCT06728059
Effectiveness of Artificial-Intelligence (AI) Bolus Priming Added to an Existing Fully Automated Control Algorithm (AIDANET)
NCT07517770
Adaptive Biobehavioral Control (ABC) in a Closed-Loop System
NCT05610111
Early Feasibility Study of Adaptive Advisory/Automated (AAA) Control of Type 1 Diabetes
NCT01939834
Therapeutic Areas
What is open in the Sue Brown pipeline
3 recruiting of 6 indexed (50% open); 1 completed (17%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Type 1 Diabetes (2 trials), 0 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Sue Brown: open-pipeline peers nationwide
Peers matched on 6 registered trials and 50% open enrollment, not the therapeutic-area sidebar.
Sue Brown sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 6 trials (± recruiting share)
- 23andMe · 6 trials · 0% recruiting
- Aardvark Therapeutics · 6 trials · 0% recruiting
- Abbisko Therapeutics Co · 6 trials · 67% recruiting
- AbGenomics B.V Taiwan Branch · 6 trials · 0% recruiting
Sponsors near 50% open enrollment (± trial volume)
- 1200 Pharma · 50% recruiting · 2 trials
- 1ST Biotherapeutics · 50% recruiting · 2 trials
- 3ive Labs · 50% recruiting · 2 trials
- 60 Degrees Pharmaceuticals · 50% recruiting · 4 trials
Related
What to do with this Sue Brown page
6 registered trials is a research-attention snapshot, not an endorsement of Sue Brown or any single study.
- 3 of Sue Brown's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Type 1 Diabetes is the condition Sue Brown studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Type 1 Diabetes trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Sue Brown pipeline card: 6 registered trials from official public datasets.Report a data error.